We’ve helped clients capture HUNDREDS of MILLIONS in value since 2007 with a proven collaborative biotechnology development process.
Our coordinated project planning and laboratory services are customized for your needs. This flexible approach delivers a cost-effective way to expand your capabilities, meet key milestones and create tangible value.
Commercialization is the ultimate goal. Results are the “Scientific Capital” that justify access to additional actual “capital”! Meaningful data helps solidify the confidence between investors and the principal investigators’ proposal.
In order to reach your next round of funding you need those results. Spending wisely early will ensure a better chance of reaching your commercialization goals.
With InfinixBio, those critical results you need to succeed are closer than you imagine.
We bring you frequent updates and share insights as we help you develop your technology. That means you stay in control of your project’s direction, timeline, and budget.
Immediately gain access to our skilled team of 25+ scientists and fully equipped research labs to help develop your technology into a product.
You get qualified, experienced, dedicated support and fully operational labs without spending your time hiring and training staff or securing lab space or equipment.
Outside expertise and perspective can benefit the outcome, so leverage those resources to bring talent to the table without adding to the operating costs of your company.
Your technology needs expert development to get to the next stage. We’ve proven our ability to foster growth, advance technology, cultivate progress and keep your project on track. Some examples of products we’ve helped develop include:
We developed methods to conjugate a novel drug delivery technology to enzymes to treat enzyme deficiency diseases for a virtual company. Besides developing and optimizing the conjugations, we also stabilized the protein constructs and increased their serum half-life via pegylation. We supported the animal trials of our conjugated enzymes and confirmed target tissue delivery and in vivo activity.
Controlling the serum half-life was key for custom Fab molecules and diabodies we produced for use in tumor imaging studies. These antibody fragments were specifically labeled with a collaborator’s proprietary PEGs to precisely regulate the clearance rate in serum. These conjugates were then used for successful tumor imaging studies.
Finding the right way to label an biologic was key when we helped a client develop a sensitive clinical diagnostic for the flu. We developed a custom labeling method, as the biomolecule lost activity using the client’s normal procedure.
Working with a cancer immunotherapy company that created a personalized adoptive cell therapy, our scientists developed a GLP compliant assays to support Phase II clinical trials. These procedures included ex vivo manipulation of patient derived blood cells to measure the production of key cytokines, establishment of cell proliferation assays, performing FACS analysis of cell surface markers, and demonstrating effective tumor cell killing by the client’s novel therapeutic. Our results will be used to support FDA approval and advance the biologic to Phase III clinical trials.
To optimize a cell-free production system, we engineered several folding enhancing chaperone genes into a specific loci on the production strain. Using synthetic DNA, we systematically engineered the strain’s chromosome to deliverer a robust protein production system while producing the required chaperone proteins in specific concentrations.
InfinixBio works with Entrepreneurs, Biotechnology Companies, Biotech Incubators and Investors to advance technology from concept to reality, making your product work better, or adapting your product to meet unmet or even unarticulated market needs. As a collaborative partner, our goal is making your product prosper.
In an ever-challenging marketplace, different situations call for flexible solutions and here at InfinixBio we can provide the personnel and tools you need to succeed!
The InfinixBio team of experienced scientists provides deep domain expertise in genes, proteins and cells that delivers creative solutions to a variety of difficult problems in Biotechnology product development. We have locations in Columbus and Athens Ohio with over 25 scientists (15 Ph.Ds) operating in our labs.
